16. Im happy to. Nkats, now just three years old, was the first new center at nih again, quite a long time and was focused in trying to identify the bottle necks from going from basic science discoveries to benefits. In collaboration with our partners in the private sector. I think initially there were some concerns that nih is becoming a drug company, that really was never the plan and is not happening now. Instead, we are identifying areas of Technology Development that no Single Company could undertake, but working with them, we can give you just one example. The effort to try to figure out when youre developing a new drug, whether its going to be safe in humans or not. Has been a real difficult one. We use animal studies, small animals, large animals. Its not that accurate. Its slow, its expensive. We probably lose drugs along the way because some mouse got a slight liver issue and it probably would have had no relevance to humans but we sort of lose the drug at that point. Wouldnt
Cancer, what we can do about it. But the other component which is a longterm ambitious to be sure effort is this cohort of a million or more americans, which we could be studying for virtually all diseases and knowing that you are a dentist i would certainly include in that such things as periodontal disease. We know the environment and genetic risk are involved in those conditions. But we really havent had a sufficiently large study with appropriate patient participation to be able to get those answers. This should be a way to go there. So thats true for diabetes, for Heart Disease, for alzheimers disease, for virtually every common condition with a million people, youre going to have enough events you should really be able to dissect, what were the biomarkers that warned this would happen what were the environmental factors that played a role. We never had that power before we aim to get it. Thats fascinating stuff, and could really advance the advancement of diseases and cure diseas
Brief recess with more questions including crypto currency, Cyber Security and hiring practices. They also touched on the economy and inflation. This is an hour and 45 minutes. The committee will come to order. The chair now recognizes the gentleman from guam, mister sam nicholas for five minutes, welcome. Thank you mister chairman, can you hear me okay . Thank you. Thank you mister chairman. I want to first begin by recognizing miss fraser and citigroup, the conversation im going to have to actually involves all the panelists but i wanted to begin with her company and herself as based on our research it looks like citigroup pays five times more in interest to its depositors than the rest of the individuals sitting at the table. Miss fraser if upcorrect your deposits are yielding. 05 percent interestrate . We believe we have, well we have a variety of different deposit products and we need them to be competitive and fair. The information i have here on your basic account policy is a. 0
07.05.2024 - ANCHORAGE, Alaska, May 06, 2024 (GLOBE NEWSWIRE) - First National Bank Alaska’s (OTCQX:FBAK) net income for the first quarter of 2024 remained stable at $13.476 million, or $4.26 per share. This compares to a net income of $13.454 million, or .